Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jul;73(7):2070-2080.
doi: 10.1111/jgs.19463. Epub 2025 Apr 12.

Impact of Comprehensive Medication Reviews on Medicare Beneficiaries With Type 2 Diabetes

Tsung-Hua Shen  1   2 , Felix Cheuk Wun Ting  1   2 , Shaquib Al Hasan  1   2 , Joel F Farley  1   2
Affiliations
Observational Study

Impact of Comprehensive Medication Reviews on Medicare Beneficiaries With Type 2 Diabetes

Tsung-Hua Shen et al. J Am Geriatr Soc. 2025 Jul.

Abstract

Background: Type 2 diabetes (T2DM) management, particularly adherence to oral antidiabetic drugs (OAD), is a key focus of the Part D Medicare Medication Therapy Management (MTM) program. Despite potential benefits, evidence on the effectiveness of MTM, specifically Comprehensive Medication Reviews (CMRs), remains mixed. To evaluate the effectiveness of CMRs on patient outcomes, we conducted the largest CMR evaluation to date among Medicare beneficiaries with T2DM.

Methods: We conducted a retrospective observational study using Medicare claims and MTM data from 2013 to 2019 to examine the impact of CMR on OAD adherence as measured by the proportion of days covered (PDC), statin utilization, emergency department (ED) visits, and hospitalization. A difference-in-difference (DiD) approach with inverse probability treatment weighting was used to reduce confounding.

Results: Although CMR recipients and nonrecipients both experienced a reduction in PDC during the follow-up, CMR recipients experienced 2.4% (95% CI, 1.9%-2.9%) less of a decline than nonrecipients, and 2.0% (95% CI, 1.2%-2.8%) fewer CMR recipients were considered non-adherent after CMR delivery. The proportion of CMR recipients using statin increased 1.4% (95% CI, 0.7%-2.2%) relative to nonrecipients after CMR delivery. The proportion of CMR recipients who experienced an ED visit declined by 0.3% (95% CI, -0.6% to 1.2%) while the proportion of hospitalization increased 1.9% (95% CI, 1.1%-2.8%) following CMR delivery, relative to nonrecipients.

Conclusion: Patients with T2DM receiving a CMR experienced improved OAD adherence and statin utilization compared to nonrecipients. Our results demonstrate the potential benefits of collaborating with pharmacists to improve diabetes care.

Keywords: Comprehensive Medication Review; Medicare; Medication Therapy Management; type 2 diabetes mellitus.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. G. Xu, B. Liu, Y. Sun, et al., “Prevalence of Diagnosed Type 1 and Type 2 Diabetes Among US Adults in 2016 and 2017: Population Based Study,” BMJ 362 (2018): k1497, https://doi.org/10.1136/bmj.k1497.
    1. K. Khunti, S. Seidu, S. Kunutsor, and M. Davies, “Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta‐Analysis,” Diabetes Care 40, no. 11 (2017): 1588–1596, https://doi.org/10.2337/dc16‐1925.
    1. A. O. Iuga and M. J. McGuire, “Adherence and Health Care Costs,” Risk Management and Healthcare Policy 7 (2014): 35–44, https://doi.org/10.2147/RMHP.S19801.
    1. “Medicare 2024 Part C & D Star Ratings Technical Notes,” 2024.
    1. “CY 2019 Medication Therapy Management Program Guidance and Submission Instructions,” 2018, published online October 23, 2024.

Publication types

MeSH terms

Substances

LinkOut - more resources